Report overview
Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.
This report contains market size and forecasts of Antidepressants Drugs in Global, including the following market information:
Global Antidepressants Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Antidepressants Drugs market was valued at 14770 million in 2021 and is projected to reach US$ 18370 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tricyclic Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antidepressants Drugs include Pfizer, AstraZeneca, Eli Lilly and Company, Novartis, GlaxoSmithKline, Otsuka Pharmaceutical, Abbott Laboratories, Gedeon Richter and Janssen Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antidepressants Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidepressants Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Antidepressants Drugs Market Segment Percentages, by Type, 2021 (%)
Tricyclic Antidepressants
Serotonin-norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Others
Global Antidepressants Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Antidepressants Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Antidepressants Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Antidepressants Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidepressants Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Antidepressants Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Eli Lilly and Company
Novartis
GlaxoSmithKline
Otsuka Pharmaceutical
Abbott Laboratories
Gedeon Richter
Janssen Pharmaceuticals
Lupin Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Naurex
SK Biopharmaceuticals
